In pancreatic cancer, NEK2 can enhance its stability through phosphorylation of PD-L1, and inhibition of NEK2 can increase lymphocyte infiltration in tumor tissue, enhance anti-tumor immune response and sensitivity to immunotherapy [25]. This evidence concerns the gene CD274 and pancreatic neoplasm.